US Stock MarketDetailed Quotes

AUPH Aurinia Pharmaceuticals

Watchlist
  • 8.160
  • +0.050+0.62%
Close Mar 14 16:00 ET
  • 8.320
  • +0.160+1.96%
Post 16:58 ET
1.12BMarket Cap204.00P/E (TTM)

About Aurinia Pharmaceuticals Company

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Company Profile

SymbolAUPH
Company NameAurinia Pharmaceuticals
Listing DateFeb 25, 2000
Founded1993
CEOMr. Peter S. Greenleaf
MarketNASDAQ
Employees130
Fiscal Year Ends12-31
Address14315 – 118 Avenue,Suite 140
CityEdmonton
ProvinceAlberta
CountryCanada
Zip CodeT5L 4S6
Phone1-250-744-2487
Websitehttp://www.auriniapharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Peter S. Greenleaf
  • President, Chief Executive Officer and Director
  • 10.57M
  • Joseph M. Miller
  • Chief Financial Officer and Principal Accounting Officer
  • 3.98M
  • Stephen P. Robertson
  • Executive Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer
  • 3.60M
  • Matthew Donley
  • Executive Vice President, Operations and Strategy
  • 4.56M
  • Kevin C. Tang
  • Director
  • --
  • Craig A. Johnson
  • Director
  • --
  • Jill D. Leversage
  • Independent Director
  • 267.28K
  • Dr. Karen L. Smith, L.L.M.,M.B.A.,M.D.,PhD
  • Independent Director
  • 359.41K
  • Dr. David R.W. Jayne, F.R.C.P.,M.D.
  • Independent Director
  • 249.92K
  • Jeffrey Allen Bailey
  • Independent Director
  • 361.51K

Trending Stocks

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
New Fortress Energy
NFE
9.260
Teradata Corp
TDC
22.690
Enerpac Tool
EPAC
43.960
4
DexCom
DXCM
70.690
5
Precision Drilling
PDS
44.680
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!